Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 4.02 is in line with its 5-year average of 4.45, around the middle of its 5-year range (0.20–7.35).
As of the fiscal period ended Friday, July 31, 2026. 26.58% below its 12-month average of 5.48.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-07-31): 4.02.
QUICK RATIO (ACID-TEST)
4.02
QUICK RATIO (ACID-TEST) AVG TTM
5.48
QUICK RATIO (ACID-TEST) AVG 3Y
4.59
QUICK RATIO (ACID-TEST) AVG 5Y
4.45
QUICK RATIO (ACID-TEST) AVG 10Y
2.84
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
-26.58%
CURRENT VS 3Y AVG
-12.44%
CURRENT VS 5Y AVG
-9.69%
CURRENT VS 10Y AVG
+41.48%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.35
median of 871 covered companies
CURRENT VS SECTOR MEDIAN
+20.08%
vs the sector median at left
Nutriband Inc.
Market Cap
$83.21M
Quick Ratio (Acid-Test)
4.02
TTM Avg
5.48
3Y Avg
4.59
5Y Avg
4.45
Market Cap
$81.88M
Quick Ratio (Acid-Test)
7.85
TTM Avg
4.70
3Y Avg
2.98
5Y Avg
5.25
Market Cap
$81.85M
Quick Ratio (Acid-Test)
16.14
TTM Avg
3.54
3Y Avg
1.85
5Y Avg
1.85
Market Cap
$80.90M
Quick Ratio (Acid-Test)
7.99
TTM Avg
9.12
3Y Avg
12.06
5Y Avg
14.25
Market Cap
$82.19M
Quick Ratio (Acid-Test)
5.74
TTM Avg
2.67
3Y Avg
4.44
5Y Avg
7.03
Market Cap
$82.20M
Quick Ratio (Acid-Test)
8.75
TTM Avg
11.02
3Y Avg
14.04
5Y Avg
18.21
Market Cap
$83.24M
Quick Ratio (Acid-Test)
3.30
TTM Avg
5.38
3Y Avg
8.10
5Y Avg
12.75
Market Cap
$79.09M
Quick Ratio (Acid-Test)
12.48
TTM Avg
10.44
3Y Avg
6.35
5Y Avg
4.72
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nutriband Inc. (NTRB) | $83.21M | 4.02 | 5.48 | 4.59 | 4.45 |
| ProMIS Neurosciences, Inc. (PMN)vs › | $81.88M | 7.85 | 4.70 | 2.98 | 5.25 |
| Telomir Pharmaceuticals, Inc. Common Stock (TELO)vs › | $81.85M | 16.14 | 3.54 | 1.85 | 1.85 |
| Acrivon Therapeutics, Inc. Common Stock (ACRV)vs › | $80.90M | 7.99 | 9.12 | 12.06 | 14.25 |
| Humacyte, Inc. (HUMA)vs › | $82.19M | 5.74 | 2.67 | 4.44 | 7.03 |
| MediciNova, Inc. (MNOV)vs › | $82.20M | 8.75 | 11.02 | 14.04 | 18.21 |
| LENSAR Inc (LNSR)vs › | $82.78M | 1.13 | 1.33 | 1.81 | 2.82 |
| Cardiff Oncology, Inc. (CRDF)vs › | $83.24M | 3.30 | 5.38 | 8.10 | 12.75 |
| vTv Therapeutics Inc. (VTVT)vs › | $79.09M | 12.48 | 10.44 | 6.35 | 4.72 |
| Atara Biotherapeutics, Inc. (ATRA)vs › | $83.61M | 1.98 | 0.61 | 1.40 | 2.59 |
Quick Ratio
4.02
Excludes inventory
Current Ratio
4.21
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-07-31 | 4.02 |
| 2026-04-30 | 5.11 |
| 2026-01-31 | 6.21 |
| 2025-10-31 | 7.35 |
| 2025-07-31 | 4.70 |
| 2025-04-30 | 3.48 |
| 2025-01-31 | 4.66 |
| 2024-10-31 | 4.83 |
| 2024-07-31 | 6.36 |
| 2024-04-30 | 6.04 |
| 2024-01-31 | 0.85 |
| 2023-10-31 | 2.54 |
| 2023-07-31 | 3.57 |
| 2023-04-30 | 2.31 |
| 2023-01-31 | 3.29 |
| 2022-10-31 | 4.21 |
| 2022-07-31 | 4.92 |
| 2022-04-30 | 6.24 |
| 2022-01-31 | 6.84 |
| 2021-10-31 | 5.80 |
| 2021-07-31 | 0.20 |
| 2021-04-30 | 0.33 |
| 2021-01-31 | 0.10 |
| 2020-10-31 | 0.11 |
| 2020-07-31 | 0.10 |
| 2020-04-30 | 0.09 |
| 2020-01-31 | 0.02 |
| 2019-10-31 | 0.19 |
| 2019-07-31 | 0.21 |
| 2019-04-30 | 0.72 |
| 2019-01-31 | 1.47 |
| 2018-10-31 | 2.10 |
| 2018-07-31 | 7.17 |
| 2018-04-30 | 0.67 |
| 2018-01-31 | 3.71 |
| 2017-10-31 | 0.73 |
| 2017-07-31 | 2.94 |
| 2017-04-30 | 0.11 |
| 2017-01-31 | 2.03 |
| 2016-10-31 | 0.02 |
| 2016-07-31 | 0.19 |
| 2016-04-30 | 2.46 |
| 2016-01-31 | 0.03 |
